Hansa Biopharma AB (publ) (STO: HNSA)
Sweden
· Delayed Price · Currency is SEK 38.88
+2.24 (6.11%)
Dec 20, 2024, 5:29 PM CET
Hansa Biopharma AB Market Cap
Hansa Biopharma AB has a market cap or net worth of 2.64 billion as of December 20, 2024. Its market cap has increased by 114.67% in one year.
Market Cap
2.64B
Enterprise Value
3.04B
Revenue
189.39M
Ranking
n/a
PE Ratio
n/a
Stock Price
38.88
Market Cap Chart
Since April 24, 2008, Hansa Biopharma AB's market cap has increased from 30.71M to 2.64B, an increase of 8,484.89%. That is a compound annual growth rate of 30.62%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca PLC | 2,234.95B |
| Swedish Orphan Biovitrum AB (publ) | 105.02B |
| Sectra AB (publ) | 52.85B |
| Getinge AB (publ) | 47.62B |
| Camurus AB (publ) | 33.79B |
| Medicover AB (publ) | 29.34B |
| Vitrolife AB (publ) | 29.03B |
| Bonesupport Holding AB (publ) | 25.19B |